TURKA LAURENCE A. (Chief Scientific Officer) sold 12.4% of their position (2.59K shares) of RUBIUS THERAPEUTICS, INC. on the open market
Open‑market sale worth $622.32 — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2023ACC: 0001104659-23-008873
Officer· Chief Scientific Officer
Since Jan 2020
-2.59K
Net shares
Net seller
$622.32
Total sold
1
Open market trades
0B · 1S
5
Total transactions
16.06K acquired · 18.66K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+7.44K
Price / share
—
Trade value
—
% of position
151.1%
1/29/2023
4.92K→12.36K
Common Stock
Direct
Shares
+8.63K
Price / share
—
Trade value
—
% of position
69.8%
1/31/2023
12.36K→20.98K
Common Stock
Direct
Shares
−2.59K
Price / share
$0.24
Trade value
$622.32
% of position
12.4%
1/31/2023
20.98K→18.39K
Total
Net shares
+13.47K
Net value
-$622.32
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/29/2023 | M · Option Exercise | +7.44K | — | — | 151.1% | 4.92K | 12.36K |
| Common Stock Direct | 1/31/2023 | M · Option Exercise | +8.63K | — | — | 69.8% | 12.36K | 20.98K |
| Common Stock Direct | 1/31/2023 | S · Sale | −2.59K | $0.24 | $622.32 | 12.4% | 20.98K | 18.39K |
| Total | +13.47K | -$622.32 | ||||||
Derivative Transactions2
Restricted Stock Units
Direct
Converts to
Common Stock
7.44K shares
Shares
−7.44K
Strike price
Held after
14.87K
Exercisable
—
1/29/2023
Restricted Stock Units
Direct
Converts to
Common Stock
8.63K shares
Shares
−8.63K
Strike price
Held after
25.88K
Exercisable
—
1/31/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.44K shares | 1/29/2023 | M · Option Exercise | −7.44K | — | 14.87K | |
| Restricted Stock Units Direct | Common Stock8.63K shares | 1/31/2023 | M · Option Exercise | −8.63K | — | 25.88K |